Back to Search
Start Over
Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials
- Source :
- The Lancet; January 2021, Vol. 397 Issue: 10268 p39-50, 12p
- Publication Year :
- 2021
-
Abstract
- Two novel type 2 oral poliovirus vaccine (OPV2) candidates, novel OPV2-c1 and novel OPV2-c2, designed to be more genetically stable than the licensed Sabin monovalent OPV2, have been developed to respond to ongoing polio outbreaks due to circulating vaccine-derived type 2 polioviruses.
Details
- Language :
- English
- ISSN :
- 01406736 and 1474547X
- Volume :
- 397
- Issue :
- 10268
- Database :
- Supplemental Index
- Journal :
- The Lancet
- Publication Type :
- Periodical
- Accession number :
- ejs54819237
- Full Text :
- https://doi.org/10.1016/S0140-6736(20)32541-1